PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403462
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1403462
According to Stratistics MRC, the Global Micro Refrigerated Centrifuge Market is at a CAGR of 3.2% during the forecast period. A micro refrigerated centrifuge is a specialized laboratory instrument designed for the separation of small volumes of biological samples through centrifugal force while also maintaining a controlled temperature environment. This device is crucial in various applications, particularly in molecular biology, biochemistry, and clinical diagnostics. This centrifuge operates by spinning samples at high speeds, causing particles or components with different densities to separate. It is suitable for handling small sample volumes with temperature control, ensuring accurate and reliable results.
Automated systems can handle a higher volume of samples concurrently, reducing turnaround times for experiments and diagnostic procedures. This is particularly crucial in time-sensitive applications, such as clinical diagnostics, where rapid results are essential for patient care. Moreover, automation minimizes manual intervention, reducing the risk of human errors and ensuring consistent performance across multiple runs contributing to the reproducibility of results, a crucial factor in scientific research which are boosting this market expansion.
The high initial costs pose a challenge for laboratories and research facilities, particularly those with limited budgets or funding constraints, which could discourage prospective purchasers from implementing automation in their processes. Moreover, this also impacts the return on investment (ROI) calculations for potential buyers, and consequently, the manufacturing and development costs of these centrifuges are high, leading to elevated purchase prices that are impeding market growth.
Innovations in robotics play a crucial role in enabling precise sample handling and processing. Advanced sensor technologies enhance the accuracy of centrifugation processes, ensuring optimal results in applications such as DNA/RNA extraction and protein purification, which contribute to the generation of high-quality, reproducible data. Additionally, integration with smart technologies, such as connectivity with laboratory information systems (LIS) and data management software, streamlines workflows and facilitates real-time monitoring of centrifuge operations, thereby driving market growth.
The absence of standardized protocols and interfaces complicates data management and communication. Different manufacturers may employ varying designs, sizes, and specifications for their centrifuge models, making it challenging to integrate them into automated systems. Furthermore, the lack of compatibility prevents laboratories from easily swapping or upgrading centrifuges without significant modifications or reconfiguration of the automation setup. This can lead to interoperability issues and hinder the market.
The COVID-19 pandemic has had negative impacts on the micro-refrigerated centrifuge automation market, affecting both demand and supply aspects of the industry. The disruptions in laboratory operations and research activities during lockdowns and restrictions have led to a slowdown in equipment purchases and upgrades. Furthermore, budget constraints and shifting priorities have resulted in postponed investments in automation technologies. This has limited the ability of laboratories to invest in new and advanced micro-refrigerated centrifuges with automation features, which has significantly hampered the market size.
The desktop segment is estimated to hold the largest share due to compact and efficient centrifuge systems designed for use on laboratory desktops. These centrifuges are characterized by their smaller footprint and user-friendly features, advanced control systems, and programmable functionalities that streamline and automate centrifugation processes. In addition, these automated desktop centrifuges are particularly used in applications such as sample preparation, nucleic acid extraction, and protein purification, which are boosting this segment's expansion.
The clinical laboratories segment is anticipated to have highest CAGR during the forecast period. These centrifuges are specifically designed to meet the stringent requirements of diagnostic laboratories and medical facilities. Automation features may include programmable protocols, touch-screen interfaces, and integration with laboratory information systems. Furthermore, these advancements contribute to standardized and high-throughput sample processing, allowing clinical laboratories to handle a large volume of samples with precision and consistency, which is driving this segment's growth.
Europe commanded the largest market share during the extrapolated period, owing to a growing demand for advanced laboratory equipment designed for efficient and automated sample processing. These advancements are led by the region's emphasis on technological innovation and a commitment to optimizing laboratory workflows with diverse applications, including molecular biology, biochemistry, and clinical diagnostics, aligning with the region's prominent position in scientific research and healthcare.
North America is expected to witness highest CAGR over the projection period. These centrifuges are designed to handle small sample volumes efficiently while incorporating automation for improved precision and workflow optimization. This region is home to some of the major players, including Kubota Corporation, Nicke-Electro Ltd., Axel Global, and Thermo Scientific. In addition, microrefrigerated centrifuges with automation features are integral to research institutions, pharmaceutical companies, and clinical laboratories, which are driving the growth of this region.
Some of the key players in the Micro Refrigerated Centrifuge Market include Axel Global, Benchmark Scientific, Inc., Eppendorf AG, Esco Scientific, Gyrozen, Hermle Labortechnik GmbH, Hitachi Koki Co., Ltd., Kubota Corporation, lab Force, Nicke-Electro Ltd., Sartorius AG, Scilogex and Thermo Scientific.
In December 2023, Thermo Fisher Scientific Inc. announced a new partnership to improve the wellbeing and treatment outcomes of adolescents and young persons living with HIV in Nigeria, the country with the second largest HIV epidemic worldwide.
In July 2023, A new benchmark has launched to bring more clarity to the definition of a high-quality carbon credit, which companies are increasingly using to offset their climate impact.
In May 2023, Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.